An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

NCT01273389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: CNTO 136
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC